Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders [Phase 1]
A Phase 1 trial comparing intravitreal and sub-tenon injections of Triamcinolone acetonide for macular edema in retinal disorders has comple…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) [Phase 2]
A Phase 2 trial evaluating retinal pigment epithelium autoimmunity in age-related macular degeneration has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders [Phase 1]
NEI-sponsored Phase 1 trial evaluated intravitreal injections of Triamcinolone Acetonide for age-related macular degeneration and retinal ve…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration [Phase 3]
A Phase 3 trial evaluating Triamcinolone Acetonide in combination with laser therapy for age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 [Phase 1]
Phase 1 trial assessing lutein, zeaxanthin, and omega-3 supplementation in people over 60 with macular degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Screening for Studies on Retinovascular Diseases
This update reports that screening for studies on retinovascular diseases sponsored by the National Eye Institute has completed, covering di…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Potential Research Participants for Future Studies of Inherited Eye Diseases
The National Eye Institute notes a completed study and describes potential participants for future studies of inherited eye diseases, includ…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants
A clinical trial investigating the effects of sun filters on age-related macular degeneration in people with lens implants has been withdraw…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Investigating Age-Related Macular Degeneration
This entry reports a completed clinical trial on age-related macular degeneration sponsored by the National Eye Institute. The snippet does …
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Genetic Study of Age-Related Macular Degeneration
This document provides a status update on a genetic study of age-related macular degeneration conducted by the National Eye Institute; the t…
-
CLINICAL_TRIALS research · 2017-06-16Clinical Trial Update: Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation [EARLY_Phase 1]
An early-phase study evaluating the transplantation of fetal retinal pigment epithelium cells for age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD [Phase 2]
A Phase 2 trial comparing sirolimus to anti-VEGF therapy for wet age-related macular degeneration has completed, with results posted in 2017…
-
FDA approval · 2017-05-26FDA Approved: EYLEA — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
FDA approved a supplemental application for EYLEA (aflibercept) submitted by Regeneron Pharmaceuticals, Inc. The action updates labeling and…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial comparing ranibizumab monotherapy with ranibizumab in combination therapies for recurrent or persistent choroidal neo…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Sparing of the Fovea in Geographic Atrophy Progression
Clinical trial update on strategies to spare the fovea during geographic atrophy progression. The study involves conditions including geogra…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of GSK933776 in adults with geographic atrophy due to age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Squalamine ophthalmic solution in neovascular age-related macular degeneration.…
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration [Phase 2]
Phase 2 trial of squalamine lactate ophthalmic solution (0.2%) for neovascular age-related macular degeneration has been withdrawn.
-
CLINICAL_TRIALS research · 2017-04-26Clinical Trial Update: Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration [NA]
Clinical trial update evaluating visual function and driving ability using Ocusweep in patients with wet age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration [Phase 2]
This clinical trial update reports the Phase 2 results of abicipar pegol in Japanese patients with neovascular age-related macular degenerat…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
This clinical trial update describes a pharmacogenomic study of the anti-VEGF drug Conbercept for macular neovascular diseases, including ag…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) [Phase 1]
A Phase I dose-escalation safety study of RetinoStat for advanced age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Reading Performance With a Video Magnifier
A completed clinical trial evaluating reading performance for individuals with age-related macular degeneration using a video magnifier.
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
This clinical trial update reports on evaluating how well physicians understand safety and safe-use information for aflibercept (Eylea) in C…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels
This clinical trial update reports on flicker fusion thresholds across multiple luminance levels, comparing younger and older subjects and i…